Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Loading Events

« All Events

BioTrinity Investor Networking Drinks 2025

March 31 @ 6:30 pm - 8:30 pm

This is an exclusive evening of networking at the BioTrinity Investor Drinks. Held the night before OBN’s premier partnering and investment conference, this event offers a valuable opportunity to connect with fellow investors from across the UK and beyond in a relaxed setting.

Co-hosted by Canary Wharf Group and Kadans Science Partner, the evening will take place on the Upper Terrace of The Alchemist, just a short walk from key transport links. Guests will enjoy drinks, substantial canapés, and the chance to engage with both new and familiar faces in the life sciences investment community.

Go to Top